Cardiovascular
Cardiovascular Disease
IDWeek 2103: The Past, Present, and Future of HIV Treatment
- Details
- Category: HIV Treatment
- Published on Friday, 11 October 2013 00:00
- Written by Liz Highleyman
More that 25 years after approval of the first antiretroviral drug -- AZT in 1987 -- several presenters at the 2nd IDWeek meeting last week in San Franciscodiscussed the history, state-of-the-art, and future of HIV treatment. Modern antiretroviral therapy (ART) has kep countless people alive, but researchers and people with HIV are now looking toward biomedical prevention and ultimately a cure.
IDWeek 2013: People with HIV Have Higher Risk of Death after Myocardial Infarction
- Details
- Category: HIV Treatment
- Published on Monday, 07 October 2013 00:00
- Written by Liz Highleyman
People with HIV had higher mortality than HIV negative individuals of the same age after hospitalization for acute coronary syndrome, but the excess risk disappeared for people on antiretroviral therapy (ART) with high CD4 T-cell counts, researchers reported last week at the Second IDWeek conference in San Francisco.
IAS 2013: HIV as a Chronic Disease [VIDEO]
- Details
- Category: HIV Treatment
- Published on Sunday, 30 June 2013 00:00
- Written by Gregory Fowler
HIV has become a chronic disease for people who have access and respond to antiretroviral therapy, but it leads to persistent immune activation and inflammation that could cause problems as people with HIV reach their 60s, 70s, and 80s, Steven Deeks from the University of California at San Francisco explained at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.
IAS 2013: Management of Age-Related Conditions Is the Future of HIV Care
- Details
- Category: HIV Treatment
- Published on Sunday, 30 June 2013 00:00
- Written by Liz Highleyman
Other diseases are becoming far more important than AIDS for people with HIV who have consistent access and good response to antiretroviral treatment, and management of age-related comorbidities will become an increasingly important aspect of HIV medicine worldwide in the coming years, Steven Deeks argued in his keynote address yesterday at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013).
IAS 2013: HIV, Inflammation, and Aging [VIDEO]
- Details
- Category: HIV Treatment
- Published on Sunday, 30 June 2013 00:00
- Written by Gregory Fowler
HIV has become a chronic disease for people who have access and respond to antiretroviral therapy, but it leads to persistent immune activation and inflammation that could cause problems as people with HIV reach their 60s, 70s, and 80s, Steven Deeks from the University of California at San Francisco said in a keynote address at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.
More Articles...
- CROI 2013: Statins for People with HIV -- How Sweet Is It?
- CROI 2013: HIV and Aging -- Are People with HIV at Greater Risk for Heart Disease and Cancer? [VIDEO]
- CROI 2013: HIV+ Men at Increased Risk for Co-morbid Conditions Regardless of Age
- CROI 2013: Heart Disease Rises Only Slighter Faster with Age for People with HIV
Web Design and Development by